Nina Seitzer

918 total citations
9 papers, 431 citations indexed

About

Nina Seitzer is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nina Seitzer has authored 9 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nina Seitzer's work include PARP inhibition in cancer therapy (4 papers), Radiation Therapy and Dosimetry (3 papers) and Cell death mechanisms and regulation (2 papers). Nina Seitzer is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Radiation Therapy and Dosimetry (3 papers) and Cell death mechanisms and regulation (2 papers). Nina Seitzer collaborates with scholars based in United States, Germany and Italy. Nina Seitzer's co-authors include Markus Reschke, Pier Paolo Pandolfi, John G. Clohessy, Axel Ullrich, Christopher Ng, Ming Chen, Andrea Lunardi, Sabina Signoretti, T. Ishikawa and Thomas Mayr and has published in prestigious journals such as Nature Medicine, Hepatology and Cancer Research.

In The Last Decade

Nina Seitzer

9 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Seitzer United States 7 266 193 106 98 76 9 431
Ilsa Coleman United States 5 203 0.8× 116 0.6× 114 1.1× 99 1.0× 70 0.9× 7 433
Antonio Agostini Norway 13 199 0.7× 115 0.6× 90 0.8× 77 0.8× 126 1.7× 26 409
Yiren Xiao United States 7 276 1.0× 130 0.7× 49 0.5× 81 0.8× 128 1.7× 11 415
Sameer A. Greenall Australia 13 203 0.8× 142 0.7× 72 0.7× 43 0.4× 91 1.2× 22 424
Zhongping Tang China 10 331 1.2× 167 0.9× 73 0.7× 104 1.1× 135 1.8× 12 494
Katrin Almstedt Germany 12 125 0.5× 270 1.4× 95 0.9× 95 1.0× 119 1.6× 33 403
Emily Pittman United States 9 205 0.8× 285 1.5× 126 1.2× 99 1.0× 96 1.3× 22 508
Marcia R. Campbell United States 9 255 1.0× 343 1.8× 103 1.0× 45 0.5× 72 0.9× 10 512
Zongming Lin China 12 226 0.8× 134 0.7× 132 1.2× 53 0.5× 99 1.3× 19 396
Octavio A. Romero Spain 12 575 2.2× 208 1.1× 95 0.9× 100 1.0× 125 1.6× 15 721

Countries citing papers authored by Nina Seitzer

Since Specialization
Citations

This map shows the geographic impact of Nina Seitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Seitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Seitzer more than expected).

Fields of papers citing papers by Nina Seitzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Seitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Seitzer. The network helps show where Nina Seitzer may publish in the future.

Co-authorship network of co-authors of Nina Seitzer

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Seitzer. A scholar is included among the top collaborators of Nina Seitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Seitzer. Nina Seitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bezzi, Marco, Nina Seitzer, T. Ishikawa, et al.. (2018). Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms. Nature Medicine. 24(2). 165–175. 134 indexed citations
2.
Ven, Anne L. van de, Paige Baldwin, Ju Qiao, et al.. (2017). Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53- Deficient Prostate Cancer to Radiation. Molecular Cancer Therapeutics. 16(7). 1279–1289. 46 indexed citations
3.
Ven, Anne L. van de, Paige Baldwin, Ju Qiao, et al.. (2017). Abstract B48: Prostate cancer pre-treatment with nanoformulated Olaparib overcomes radiation resistance. Cancer Research. 77(2_Supplement). B48–B48. 1 indexed citations
4.
Baldwin, Paige, Anne L. van de Ven, Nina Seitzer, et al.. (2016). Nanoformulation of the PARP Inhibitor Olaparib Enables Radiosensitization of a Radiation-Resistant Prostate Cancer Model. International Journal of Radiation Oncology*Biology*Physics. 96(2). E595–E595. 2 indexed citations
5.
Lunardi, Andrea, Shohreh Varmeh, Ming Chen, et al.. (2015). Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis. Cancer Discovery. 5(5). 550–563. 22 indexed citations
6.
González‐Billalabeitia, Enrique, Nina Seitzer, Su Jung Song, et al.. (2014). Vulnerabilities of PTENTP53 -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition. Cancer Discovery. 4(8). 896–904. 80 indexed citations
7.
Reschke, Markus, John G. Clohessy, Nina Seitzer, et al.. (2013). Characterization and Analysis of the Composition and Dynamics of the Mammalian Riboproteome. Cell Reports. 4(6). 1276–1287. 42 indexed citations
8.
Seitzer, Nina, Thomas Mayr, Sylvia Streit, & Axel Ullrich. (2010). A Single Nucleotide Change in the Mouse Genome Accelerates Breast Cancer Progression. Cancer Research. 70(2). 802–812. 41 indexed citations
9.
Reschke, Markus, Ingvar Ferby, Ewa Stępniak-Konieczna, et al.. (2009). Mitogen‐inducible gene‐6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma†. Hepatology. 51(4). 1383–1390. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026